ValiRx PLC | Income Statement
Fiscal year is January-December. All values GBP Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
124.90
87.60
-
-
-
143
Cost of Goods Sold (COGS) incl. D&A
82.20
106.60
102.70
102.80
187.70
143
Gross Income
42.70
19.10
102.70
102.80
187.70
143
SG&A Expense
2,953.80
3,329.90
2,802.80
4,066.80
3,021.10
4,225.50
EBIT
2,911.10
3,348.90
-
4,169.60
3,208.80
4,368.50
Unusual Expense
-
72.20
463.00
1,243.60
20.70
455.90
Non Operating Income/Expense
0.20
228.20
1.70
-
83.50
3.90
Interest Expense
-
-
-
338.20
449.90
0.90
Pretax Income
2,905.70
3,641.30
2,239.80
5,751.40
3,554.00
4,829.10
Income Tax
308.50
396.90
391.20
620.10
416.30
461.30
Consolidated Net Income
2,597.20
3,244.50
1,848.60
5,131.30
3,137.60
4,367.80
Net Income
2,597.20
3,160.00
1,791.00
4,930.80
3,019.70
4,298.80
Net Income After Extraordinaries
2,597.20
3,160.00
1,463.70
5,113.50
3,019.70
4,298.80
Net Income Available to Common
2,597.20
3,160.00
2,118.30
5,289.80
3,019.70
4,298.80
EPS (Basic)
0.19
0.14
0.07
0.08
0.02
0.01
Basic Shares Outstanding
13,864.90
23,531.10
31,789.50
57,743.20
151,071.00
458,715.80
EPS (Diluted)
0.19
0.13
0.07
0.08
0.02
0.01
Diluted Shares Outstanding
13,864.90
23,531.10
31,789.50
57,743.20
151,071.00
458,715.80
EBITDA
2,849.90
3,257.70
2,599.40
4,066.80
3,021.20
4,225.50
Other Operating Expense
-
-
203.40
-
-
-
Non-Operating Interest Income
5.60
8.00
1.10
0.00
0.50
-
Minority Interest Expense
-
84.40
57.60
200.50
118.00
69
About ValiRx
View Profile
